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Background: Oral squamous cell carcinoma (OSCC) is the eighth most prevalent cancer worldwide. In recent
large-scale studies, by immunohistochemistry and cluster analysis, several markers were associated with patient
survival in various tumors. The aim of this study was to analyze the expression profiles of 23 proteins that have
been linked to the inhibition (Bcl-2, Bcl-x, Bcl-xL, Bcl-2-related protein A1, BAG-1, and survivin) and promotion
(Bak, Bax, Bim/Bod, Bim-Long, Bad, Bid, PUMA, Apaf-1, caspase-2, caspase-3, caspase-6, caspase-7, caspase-8,
caspase-9, caspase-10, Smac/DIABLO, and cytochrome c) of apoptosis in OSCC.
Methods: Two-hundred and twenty nine cases of OSCC, arranged in a tissue microarray, were immunohistochemically
analyzed, and the results were quantified on an automated imaging system. The data were analyzed using a random
forest clustering method.
Results: Overall protein expression patterns defined two chief clusters: an anti-apoptotic cluster (142 cases) and a
pro-apoptotic cluster (29 cases). These groups could not be explained by any clinical or pathological characteristic,
and overall and disease-free survival did not differ between them.
Conclusions: Although there was no association with survival, the cluster analysis demonstrated specific protein
profiles that could be of interest for using targeted therapies: in one of the clusters, the expression of pro-apoptotic
proteins was more prominent, demonstrating a pro-apoptotic profile and highlighting the importance of apoptosis
during OSCC development.
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Oral squamous cell carcinoma (OSCC) is the eighth
most prevalent cancer worldwide [1, 2]. In Brazil, the
National Cancer Institute estimates that 11,140 males
and 4350 females develop oral cancer annually [3].
Many studies have identified various changes in gene
expression in head and neck squamous cell carcinomas
compared with normal oral mucosa, identifying sub-
groups of head and neck squamous cell carcinomas
with profiles that correlate with many aspects of
prognosis [4–7].* Correspondence: ccamilo@cipe.accamargo.org.br
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(http://creativecommons.org/publicdomain/zeMolecular profiling by gene array and its translation
into surrogate immunohistochemistry profiles is affecting
the classification and management of tumors, such as
endometrial, breast, gastric cancer, and brain tumors
[8–13]. It is important that similar approaches be
taken to increase our understanding of OSCC.
The changes that have been observed in such molecular
studies affect a wide range of processes that mediate the
development of many cancers [4]. One of these processes
is apoptosis. The primary function of apoptosis is to elim-
inate senescent or altered cells that are useless or harmful
to a multicellular organism. Altered expression levels of
apoptosis-related proteins have been reported in several
cancers, including OSCC [14–16]. The development of
resistance to apoptosis is a hallmark of malignant cells,le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Table 1 Clinicopathological characteristics of the oral squamous
cell carcinoma patients
Variables Categories Number of patients (%)
Age (years) <= 56 117 (51.1)
>56 112 (48.9)
Gender Male 194 (84.7)
Female 35 (15.3)
Tobacco smoking No 19 (8.3)
Yes 182 (79.5)
n/aa 28 (12.2)
Alcohol consumption No 45 (19.7)
Yes 153 (66.8)
n/a 31 (13.5)
T stage T1/T2 131(57.2)
T3/T4a 98 (42.8)
Clinical Stage I/II 77 (33.6)
III/IV 152 (66.4)
Tumor site Oral tongue 122 (53.3)
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environmental signals and the loss of normal survival
signals [17, 18].
Two pathways initiate apoptosis, both of which activate
the executioner caspases 3, 6, and 7. The first pathway is
the intrinsic, or mitochondrial, pathway, because mito-
chondria control the initiation of apoptosis. Apoptotic
stimuli induce the release of cytochrome c and other
apoptotic regulators from the intermembrane space of
mitochondria. In the cytosol, cytochrome c, APAF-1, ATP,
and the initiator procaspase 9 form the apoptosome,
which effects the cleavage of effector caspases. The Bcl-2
family of proteins regulates mitochondrial permeability.
The second pathway is known as the extrinsic pathway; it
is mediated by various death receptors on the cell surface.
These receptors, once activated by specific ligands,
initiates the recruitment of FAS-associated death domain
protein and procaspases 8 and 10 to the death domain,
which forms the death inducing signaling complex and
promotes the activation of caspase 8 [16, 19].
The aim of this study was to analyze the expression
profiles of 23 proteins that are associated with both
apoptosis pathways in a series of 229 cases of OSCC.
Hierarchical cluster analysis was performed to identify
apoptotic molecular subtypes of OSCC and determine if
these different profiles are related to patient outcomes.Perineural infiltration No 129 (56.3)
Yes 86 (37.6)
n/a 14 (6.1)
Vascular invasion No 72 (31.4)
Yes 141 (61.6)
n/a 16 (7.0)





Treatment Surgery 118 (51.5)
Surgery + Radiotherapy 111 (48.5)
an/a, information not availableMethods
Tissue samples
Paraffin-embedded tissue samples from 229 oral squamous
cell carcinoma cases and 10 non-neoplastic samples from
oral mucosa tissue adjacent to tumor were obtained from
the files of the Department of Pathology of the A.C.
Camargo Cancer Center, São Paulo, Brazil. All retrieved
cases had been untreated, underwent surgery as the initial
treatment at the hospital and have been followed-up for at
least 5 years. Clinical and histological details of the
cases are provided in Table 1. This study was approved by
the AC Camargo Cancer Center Ethics Committee
(Protocol number 985/07) and complied with the Helsinki
Declaration guidelines.Tissue microarray (TMA)
To construct the TMA, H&E sections were analyzed,
and a representative area of the deepest tumor sheet was
marked on the slide. The tissues that corresponded to
the selected areas were sampled from the donor block
using a tissue microarrayer (Beecher Instruments, Silver
Springs, USA). Each sample was arrayed twice with a
1.0-mm-diameter core that was spaced 0.2 mm apart,
and two TMAs with different core regions were con-
structed. After the array was completed, the TMA blocks
were sectioned at a thickness of 4 μm.Immunohistochemistry
The expression of Bcl-2, Bcl-x, Bcl-xL, Bcl-2-related
protein A1, BAG-1, Bak, Bax, Bim/Bod, Bim-Long, Bad,
Bid, PUMA, Apaf-1, caspase-2, caspase-3, caspase-6,
caspase-7, caspase-8, caspase-9, caspase-10, Smac/DIA-
BLO, cytochrome c, and survivin was examined in
OSCC tissue samples in a TMA [14,15]. Immunostaining
was performed on two tissue slides from different cores
of the same sample. The slides were deparaffinized, rehy-
drated, and subjected to antigen retrieval. Details on the
antigen retrieval methods and primary antibodies clones,
sources, and titers are listed in Table 2. The sections
Table 2 Primary serum, clones, source, working titers, and antigen retrieval
Primary serum Clone Source Working titer Antigen retrieval
Bcl-2 124 Dako 1:200 Citrate pH 6.0
Bcl-x polyclonal Dako 1:500 Citrate pH 6.0
Bcl-xL 7D9 Chemicon 1:2000 Citrate pH 6.0
Bcl-2 related protein A1 EP517Y Epitomics 1:150 Citrate pH 6.0
BAG-1 3.10G3E2 Neomarkers 1:100 EDTA/Tris pH 9.0
Bak polyclonal Dako 1:300 Citrate pH 6.0
Bax polyclonal Dako 1:400 Citrate pH 6.0
Bim/Bod polyclonal Neomarkers 1:150 EDTA/Tris pH 9.0
Bim Long 5E5 Chemicon 1:100 Citrate pH 6.0
Bad Y208 Epitomics 1:1500 EDTA/Tris pH 9.0
Bid BH3 Epitomics 1:200 Citrate pH 6.0
PUMA EP512Y Epitomics 1:250 Citrate pH 6.0
APAF1 polyclonal Novocastra 1:30 Citrate pH 6.0
Caspase 2 Y154 Epitomics 1:100 EDTA/Tris pH 9.0
Cleaved Caspase 3 polyclonal Cell Signaling 1:600 Citrate pH 6.0
Caspase 6(c-term) E180 Epitomics 1:150 EDTA/Tris pH 9.0
Caspase 7 7CSP01 Chemicon 1:150 EDTA/Tris pH 9.0
Caspase 8 11B6 Novocastra 1:250 Citrate pH 6.0
Caspase 9p10 H83 Santa Cruz 1:500 Citrate pH 6.0
Caspase 10 pro E35 Epitomics 1:600 Citrate pH 6.0
Smac/Diablo Y12 Epitomics 1:100 Citrate pH 6.0
Cytochrome c CTC05 Chemicon 1:3000 Citrate pH 6.0
Survivin polyclonal Neomarkers 1:400 EDTA pH 8.0
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15 min to quench endogenous peroxidase activity and
with Protein Block Serum-Free (Dako, CA, USA) for
20 min at room temperature to suppress nonspecific
binding of subsequent reagents.
The sections were then incubated with primary anti-
body for 2 h at room temperature. The antigen-antibody
complexes were visualized using the Advance Detection
System (Dako, CA, USA) and incubated with 3’3 diamino-
benzidine tetrachloride (DAB) (Dako, CA, USA) for
5 min, and the sections were counterstained with Mayer’s
hematoxylin, dehydrated, and mounted with a glass
coverslip and xylene-based mounting media. The
results were quantified on an automated imaging sys-
tem (ACIS III, Dako, CA, USA), which detects levels
of hue, saturation, and luminosity, converting this sig-
nal into a numerical measurement of density (staining
intensity) that ranges from 0 to 256. Qualitative
analysis of the results considered the distribution of
the protein (nucleus, cytoplasmic and membrane), the
pattern of staining (diffuse or focal) and the intensity
of staining (strong, moderate, weak). Negative con-
trols were performed by replacing the primary serumwith a non-immune reagent. Positive controls were
used per the manufactures’ recommendations.
Cluster analysis
Hierarchical cluster analyses were performed using a ran-
dom forest clustering method (TMEV, http://mev.tm4.org/),
and the results were displayed using Tree-View. This
method is an unsupervised learning method that cre-
ates molecular classifications, based on distinct global
expression profiles, blinded to clinic and pathological
covariates. Samples that did not presented
interpretable protein expression in more than 80% of
the 23 proteins analyzed were excluded from hier-
archical cluster analysis.
Terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL)
TUNEL assay was performed using Apoptag S7100
(Milipore) according to the manufacturer’s protocol.
The slides were deparaffinized, rehydrated, and subjected
to proteinase K treatment. The sections were incubated in
3% aqueous hydrogen peroxide for 5 min to quench
endogenous peroxidase activity. The sections were then
Coutinho-Camillo et al. Applied Cancer Research  (2017) 37:2 Page 4 of 10incubated with TdT enzyme working solution for 1 h at
37 °C, followed by incubation with anti-dig conjugate for
30 min at room temperature. The reaction was developedFig. 1 Expression of apoptotic proteins in oral squamous cell carcinoma. a
X250); b Bcl-x (original magnification X250); c Bcl-xL (original magnification
e BAG-1 (original magnification X400); f1 Bax (original magnification X400);
X400); h Bim-Long (original magnification X400); i Bad (original magnification
X400); l APAF (original magnification X400)with TSA incubation for 8 min at room temperature. The
sections were mounted with a glass coverslip and xylene-
based mounting media.1 Bcl-2 (original magnification X400); a2 Bcl-2 (original magnification
X400); d Bcl-2 related protein a1 (original magnification X400);
f2 Bak (original magnification X250); g Bim/Bod (original magnification
X400); j Bid (original magnification X250); k PUMA (original magnification
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The association of the demographic, clinical and patho-
logical characteristics of the patients with protein expres-
sion profiles between clusters was analyzed by chi-square
test. Overall and disease-free survival probabilities were
calculated, based on the Kaplan-Meier method, and log-
rank test was used to determine statistical significance.
The significance level was 5% for all statistical tests.
Statistical analyses were performed using R, version 2.13
(R Development Core Team (2010), Vienna, Austria,
www.R-project.org).
Results
All antiapoptotic (Bcl-2, Bcl-x, Bcl-xL, Bcl-2-related
protein A1, BAG1, survivin) and proapoptotic (Bak, Bax,
Bim/Bod, Bim-Long, Bad, Bid, PUMA, Apaf-1, caspase-
2, caspase-3, caspase-6, caspase-7, caspase-8, caspase-9,
caspase-10, Smac/Diablo, cytochrome c) proteins were
expressed in the oral squamous cell carcinoma (OSCC)
samples (Figs. 1 and 2). The proteins varied in expres-
sion, and all were cytoplasmic in neoplastic cells and
positive controls, except survivin that was expressed in a
cytoplasmatic and/or nuclear pattern. Staining for Bad
was robust in well-differentiated tumors. This pattern
was also observed with Bcl-xL, which was strong in
the fronts of invasive areas. Bcl-2-related protein A1Fig. 2 Expression of apoptotic proteins in oral squamous cell carcinoma. a ca
X250); c caspase 6 (original magnification X250); d caspase 7 (original magnifi
(original magnification X250); g caspase 10 (original magnification X250); h Sm
magnification X250); j survivin (original magnification X400)expression was strong in well-differentiated tumors,
concentrated in the cytoplasm of keratinizing neoplas-
tic cells that surrounded keratin pearls. There was no
difference in the pattern of distribution of the stain-
ing of the other proteins in tumors. All proteins were
expressed in non-neoplastic oral squamous mucosa in the
middle and lower layers. These results are described in
Table 3.
Hierarchical cluster analysis was performed after the
exclusion of the samples with values that were missing
in more than 20% of the 23 proteins. Therefore, 171
samples were allocated for the analysis. The combined
protein expression patterns defined two clusters: cluster
A (142 cases) and cluster B (29 cases; Fig. 3).
Nine proteins (BAG-1, Bcl-2, Bid, Bim/Bod, Bax,
caspase-2, caspase-6, caspase-7, Smac/Diablo) were
expressed equally between clusters. Apaf-1, caspase-3,
caspase-9, cytochrome c, caspase-10, PUMA, survivin,
Bad, Bak, Bcl-2-related protein A1, Bcl-x, Bcl-xL, and
Bim-Long proteins were preferentially expressed in cluster
B (p <0.0001, p < 0.001, p < 0.001, p = 0.001, p = 0.001,
p < 0.001, p = 0.007, p = 0.024, p = 0.028, p < 0.001, p <
0.001, p < 0.001 and p = 0.006, respectively), and
caspase-8 was predominant in cluster A (p < 0.001)
(Fig. 4). Based on the distribution of proteins in the
clusters, we defined cluster A as the “anti-apoptoticspase 2 (original magnification X250); b caspase 3 (original magnification
cation X400); e caspase 8 (original magnification X400); f caspase 9
ac/DIABLO (original magnification X250); i cytchrome c (original
Table 3 Results of immunostaining quantitatively analyzed using an automated imaging system (ACIS III)
Protein Intensity (range) Median value of intensity Intensity (range) Median value of intensity
Neoplastic cells Normal cells
Bcl2a 52.0–80.0 55.0 56.0–57.0 57.0
Bcl-xa 66.0–106.0 74.0 83.3–96.0 84.0
Bcl-xLa 109.5–156.0 136.9 80.7–95.0 83.0
Bcl-2 related protein A1a 78.5–128.0 93.8 74.7–87.0 79.2
BAG-1/RAP46a 69.0–102.0 77.0 68.0–76.0 74.6
Baka 90.0–142.0 114.5 88.5–101.3 98.5
Baxa 99.0–138.3 114.5 74.0–75.0 74.7
Bim/Boda 65.0–98.3 77.2 65.3–71.5 66.5
BIM-Longa 81.0–130.0 101.5 81.0–85.5 82.9
Bad (N-term)a 70.0–121.5 85.0 75.0–84.5 78.5
Bida 65.5–98.5 76.5 62.3–65.0 63.5
Pumaa 61.0–115.0 80.5 97.5–117.0 113.8
APAF1 102.0–150.0 124.0 83.0–93.0 87.0
Caspase 2 58.0–83.2 63.4 58.0–66.0 63.0
Cleaved Caspase 3b 68.8–107.0 81.0 61.0–73.0 62.5
Caspase 6 (c-term)b 63.0–90.0 74.0 62.0–82.0 66.5
Caspase 7b 69.5–107.5 80.3 65.0–72.0 66.0
Caspase 8b 85.0–151.0 115.4 78.0–115.0 82.0
Caspase 9p10b 90.5–138.0 107.0 55.0–68.0 59.0
Caspase 10 prob 67.0–91.5 77.0 60.0–70.0 61.0
Smac/Diablo 72.0–135.8 90.0 71,0–83.0 74.0
Cytochrome c 63.0–87.0 73.0 63.0–71.0 70.5
Survivin 66.0–97.0 80.1 73.0–85.0 80.5
aImmunohistochemical data described in Coutinho-Camillo et al. [15]
bImmunohistochemical data described in Coutinho-Camillo et al. [16]
Fig. 3 Two-way hierarchical cluster analysis of 171 oral squamous cell carcinomas based on the expression of 23 proteins. Tumors were grouped
into 2 clusters (A and B), based on the protein expression profile. Rows represent proteins, ordered according to their hierarchical distances.
Colors in columns represent expression levels: red indicates positive staining, and green represents the absence of staining for each of the
antibodies. Within each cluster, samples were ordered based on their correlation distances
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Fig. 4 Box-plots of protein expression by clusters of oral squamous cell carcinoma samples
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Figure 5 shows the occurrence of apoptosis in OSCC
samples using TUNEL assay. The apoptotic cells were
mainly detected in areas with evidence of keratin
pearl formation. The protein expression profile in
cases that demonstrated apoptosis by TUNEL assay
was similar to “pro-apoptotic cluster”, however no
statistical significance was observed.
To determine whether these two clusters represented
clinically distinct subgroups of patients, univariate
analysis was performed. Significant associations between
clusters and clinical/pathological findings, such as loca-
tion and histological grade, were not observed (Table 4).Fig. 5 TUNEL analysis in oral squamous cell carcinoma samples. a and b A
cells in areas of keratin pearls: evidence of chromatin fragmentation (arrowFive-year overall and disease-free survival rates did not
differ between clusters A and B (p = 0.69 and p = 0.68,
respectively).Discussion
Alterations in the expression levels of apoptosis-related
proteins have been reported in several cancers, including
oral cancer [14–16]. In this study, by tissue microarray
(TMA) analysis of 229 oral squamous cell carcinoma
(OSCC) cases, the expression profiles of 23 apoptotic
proteins were examined and a hierarchical cluster ana-
lysis was performed.poptosis in squamous cell carcinoma keratinizing areas. TUNEL-positive
s) (original magnification X600)
Table 4 Association between clusters and clinical and pathological findings
Cluster
Variable Category A B Total p-value
Tumor site Oral tongue 72 (82.0) 16 (18.0) 88 0.1225
Floor of mouth 32 (76.0) 10 (24.0) 42
Other 38 (93.0) 3 (7.0) 41
T stage T1/T2 73 (82.0) 16 (18.0) 89 0.7116
T3/T4a 69 (84.0) 13 (16.0) 82
Clinical stage I/II 38 (79.0) 10 (21.0) 48 0.3990
III/IV 104 (85.0) 19 (15.0) 123
Histological grade Well differentiated 108 (81.0) 25 (19.0) 133 0.4002
Moderately differentiated 26 (90.0) 3 (10.0) 29
Poorly differentiated 3 (100.0) 0 (0.0) 3
Vascular invasion No 43 (81.0) 10 (19.0) 53 0.4956
Yes 93 (85.0) 16 (15.0) 109
Perineural infiltration No 74 (80.0) 19 (20.0) 93 0.2045
Yes 61 (87.0) 9 (13.0) 70
Lymph node metastasis No 59 (86.0) 10 (14.0) 69 0.7312
Yes 76 (84.0) 15 (16.0) 91
Coutinho-Camillo et al. Applied Cancer Research  (2017) 37:2 Page 8 of 10More than 60 gene expression-profiling studies of
human clinical samples of head and neck squamous cell
carcinoma (HNSCC) have been published. Unfortunately,
these profiles have failed to effect any clinically relevant
application in the management of HNSCC [20, 21].
Several studies have identified gene expression profiles
that differ between normal mucosa, premalignant lesions,
and invasive carcinoma. Other studies focused on tumor
classification, prognostic or predictive value based on
molecular characteristics [22–26].
Molecular profiling by gene array and its translation
into surrogate immunohistochemistry profiles are being
applied to classify and manage various tumors. Cluster
analysis has been used, allowing one to make a more
objective interpretation of immunoprofiles, based on
staining with multiple antibodies, and holding great
promise for the immunohistochemical classification of
tumors [8–13]. Tissue microarrays have become a widely
used tool to screen for protein expression patterns in a
large number of tumors and these data could be used to
classify tumors and determine whether these putative
classes (clusters) are biologically and clinically meaning-
ful [27].
Apoptosis has a significant function in OSCC. Based
on the expression of 23 proteins, our group have demon-
strated that decreased expression of caspase-3 correlates
with lymph node metastasis, lower caspase-7 levels are as-
sociated with disease-free survival in oral cancer, high
Bim-Long expression is linked to overall survival and that
elevated PUMA levels are associated with disease-free sur-
vival in oral cancer patients [15, 16]. Elevated expressionof Apaf-1 and survivin is associated with the absence of
embolization, and the expression of Smac/DIABLO and
cytochrome c is not significantly associated to any clinico-
pathological characteristic (unpublished results).
The contradictory results regarding the prognosis
and expression of apoptotic proteins indicate that the
induction of apoptosis is complex and that the influ-
ence of individual proteins varies between tumors.
Further, the balance between anti- and proapoptotic
proteins determines cell fate. In this study, a hierarch-
ical cluster analysis was performed to identify protein
profiles, which could distinguish different subtypes of
OSCC, and how they relate to patient outcomes.
Overall protein expression patterns defined two chief
clusters: an anti-apoptotic cluster (142 cases) and a
pro-apoptotic cluster (29 cases). These groups could
not be explained by any clinical or pathological character-
istic, and overall and disease-free survival did not differ
between them. Although there was no association with
survival, the cluster analysis demonstrated specific protein
profiles that could be of interest for using targeted
therapies: in one of the clusters, the expression of
pro-apoptotic proteins was more prominent, demon-
strating a pro-apoptotic profile and highlighting the
importance of apoptosis during OSCC development.
First studies in HNSCC focused on discriminatory
profiles between normal and tumor samples [28–30].
Chung et al. [22] was the first group to classify HNSCC
into prognostic groups based on gene expression profiles
of 60 samples from different tumor sites. Zanaruddin
et al. [31], using a panel of 11 proteins previously shown
Coutinho-Camillo et al. Applied Cancer Research  (2017) 37:2 Page 9 of 10to have a prognostic significance in HNSCC, described a
4-protein signature that predicts lymph node metastasis
and survival in oral squamous cell carcinoma. Box et al.
[32] identified a protein signature associated with EGFR-
TKI resistance in head and neck squamous cell carcin-
oma cell lines.
Walter et al. [33] analyzed gene expression profile of
138 HNSCC samples from different sites and reported
the same groups described by Chung et al. [22]. However,
they did not observed an association between recurrence-
free survival and tumor subtype. Méndez et al. [34]
described 314 genes differentially expressed between
tumor and normal samples. However, considering patient’s
outcome only one gene was differentially expressed
between metastatic and non-metastatic tumors.
These apparent conflicting results regarding prognostic
findings presented by different studies might be due to the
use of different array platforms, analytical procedures,
tumor sample selection, number of patients evaluated,
and different endpoints evaluated [7, 20, 21].
One of the limitations of this study is the lack of data
on other critical cellular pathways, besides apoptosis.
Another possible limitation of this study is the use of
Tissue microarrays, due to intra-tumor heterogeneity of
protein expression. However, increasing the number of
cores collected from the sample and/or increasing the
core diameter can circumvent this limitation [35, 36].
Furthermore, the use of an automated scoring system
enables a more objective and quantitative acquisition of
staining result measurements due to its higher accuracy,
sensitivity and better reproducibility of data [36, 37].
Despite these limitations, this study was able to demon-
strate different biological behavior in OSCC. Further
validation using another cohort and in vivo studies are
necessary to evaluate if the cluster analysis could be
predictive of response to therapeutic interventions.
In summary, the expression 23 apoptosis-related
proteins was evaluated on 229 OSCC samples arranged
on a tissue microarray. Although hierarchical cluster
analysis identified two clusters, no significant associa-
tions between the clusters and clinical and pathological
findings were observed. Based on the expression profiles
of the clusters, a pro-apoptotic cluster and an anti-
apoptotic cluster were defined, suggesting that apoptosis
is linked to tumor behavior in OSCC.Conclusions
Our results suggested that apoptosis is present in OSCC,
but other mechanisms of cell growth outcome those
of cell-death. This information may be of value in
establishing new approaches to investigate the complex
molecular roads that lead to uncontrolled cell proliferation
in malignant neoplasms.Abbreviations
DAB: 3’3 diaminobenzidine tetrachloride; OSCC: Oral squamous cell
carcinoma; TMA: Tissue microarray; TUNEL: Terminal deoxynucleotidyl
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